Colony Capital, Inc (NYSE: CLNY) is a leading global investment management firm with assets under management of $43 billion. The Company manages capital on behalf of its stockholders, as well as institutional and retail investors in private funds, non-traded and traded real estate investment trusts and registered investment companies. The Company has significant holdings in: (a) the healthcare, industrial and hospitality property sectors; (b) Colony Credit Real Estate, Inc (NYSE: CLNC) and NorthStar Realty Europe Corp.
Read More…
Industry, Sector and Symbol
Industry Real estate investment trusts
Sub-IndustryMortgage REITs
SectorFinance
Phone310-282-8820
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$2.67 billion
Profitability
Miscellaneous
Employees400
Next Earnings Date11/6/2019 (Estimated)
OptionableOptionable
Colony Capital (NYSE:CLNY) Frequently Asked Questions
What is Colony Capital's stock symbol?
Colony Capital trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLNY."
How often does Colony Capital pay dividends? What is the dividend yield for Colony Capital?
Colony Capital announced a quarterly dividend on Tuesday, August 6th. Investors of record on Monday, September 30th will be given a dividend of $0.11 per share on Tuesday, October 15th. This represents a $0.44 dividend on an annualized basis and a yield of 7.73%. The ex-dividend date of this dividend is Friday, September 27th. View Colony Capital's Dividend History.
How were Colony Capital's earnings last quarter?
Colony Capital Inc (NYSE:CLNY) issued its quarterly earnings data on Friday, August, 9th. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts' consensus estimates of $0.14 by $0.03. The real estate investment trust earned $573.40 million during the quarter, compared to the consensus estimate of $669.45 million. Colony Capital had a negative return on equity of 9.60% and a negative net margin of 36.96%. The company's quarterly revenue was down 16.9% compared to the same quarter last year. During the same period in the previous year, the business posted $0.18 earnings per share. View Colony Capital's Earnings History.
When is Colony Capital's next earnings date?
What price target have analysts set for CLNY?
2 Wall Street analysts have issued twelve-month target prices for Colony Capital's stock. Their predictions range from $8.00 to $9.00. On average, they expect Colony Capital's stock price to reach $8.50 in the next twelve months. This suggests a possible upside of 49.4% from the stock's current price. View Analyst Price Targets for Colony Capital.
What is the consensus analysts' recommendation for Colony Capital?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colony Capital in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Colony Capital.
Has Colony Capital been receiving favorable news coverage?
Headlines about CLNY stock have trended negative this week, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Colony Capital earned a news sentiment score of -2.9 on InfoTrie's scale. They also gave media headlines about the real estate investment trust a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the near future. View News Stories for Colony Capital.
Are investors shorting Colony Capital?
Colony Capital saw a decrease in short interest in the month of August. As of August 31st, there was short interest totalling 9,058,900 shares, a decrease of 8.7% from the July 31st total of 9,927,500 shares. Based on an average daily volume of 2,640,000 shares, the days-to-cover ratio is currently 3.4 days. Approximately 1.9% of the shares of the stock are sold short. View Colony Capital's Current Options Chain.
Who are some of Colony Capital's key competitors?
Some companies that are related to Colony Capital include Camden Property Trust (CPT), Federal Realty Investment Trust (FRT), SINO LD LTD/S (SNLAY), VICI Properties (VICI), Klepierre (KLPEF), Iron Mountain (IRM), Vereit (VER), Omega Healthcare Investors (OHI), AGNC Investment (AGNC), National Retail Properties (NNN), Medical Properties Trust (MPW), CyrusOne (CONE), Kimco Realty (KIM), Gaming and Leisure Properties (GLPI) and Store Capital (STOR).
What other stocks do shareholders of Colony Capital own?
Who are Colony Capital's key executives?
Colony Capital's management team includes the folowing people:
- Mr. Thomas Joseph Barrack Jr., Founder, Exec. Chairman & CEO (Age 70)
- Mr. Darren J. Tangen, Pres (Age 48)
- Mr. Kevin P. Traenkle, Exec. VP & Chief Investment Officer (Age 49)
- Mr. Mark Melvin Hedstrom CPA, Exec. VP, COO & CFO (Age 60)
- Mr. Neale W. Redington, MD & Chief Accounting Officer (Age 52)
Who are Colony Capital's major shareholders?
Colony Capital's stock is owned by a number of of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (14.04%), BlackRock Inc. (6.71%), Caisse DE Depot ET Placement DU Quebec (6.52%), Fosun International Ltd (1.39%), Charles Schwab Investment Management Inc. (0.95%) and Nuveen Asset Management LLC (0.93%). Company insiders that own Colony Capital stock include Craig M Hatkoff, Neale Redington and Raymond C Mikulich. View Institutional Ownership Trends for Colony Capital.
Which major investors are selling Colony Capital stock?
CLNY stock was sold by a variety of institutional investors in the last quarter, including Fosun International Ltd, BlackRock Inc., Tensile Capital Management LLC, Bank of America Corp DE, Asset Management One Co. Ltd., Jennison Associates LLC, Jennison Associates LLC and Wells Fargo & Company MN. View Insider Buying and Selling for Colony Capital.
Which major investors are buying Colony Capital stock?
CLNY stock was bought by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Caisse DE Depot ET Placement DU Quebec, Charles Schwab Investment Management Inc., Renaissance Technologies LLC, Boston Partners, Prudential Financial Inc., Parametric Portfolio Associates LLC and First Trust Advisors LP. Company insiders that have bought Colony Capital stock in the last two years include Craig M Hatkoff and Raymond C Mikulich. View Insider Buying and Selling for Colony Capital.
How do I buy shares of Colony Capital?
Shares of CLNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Colony Capital's stock price today?
One share of CLNY stock can currently be purchased for approximately $5.69.
How big of a company is Colony Capital?
Colony Capital has a market capitalization of $2.78 billion and generates $2.67 billion in revenue each year. The real estate investment trust earns $-519,610,000.00 in net income (profit) each year or $0.62 on an earnings per share basis. Colony Capital employs 400 workers across the globe.View Additional Information About Colony Capital.
What is Colony Capital's official website?
How can I contact Colony Capital?
Colony Capital's mailing address is 515 SOUTH FLOWER STREET 44TH FLOOR, LOS ANGELES CA, 90071. The real estate investment trust can be reached via phone at 310-282-8820 or via email at [email protected]
MarketBeat Community Rating for Colony Capital (NYSE CLNY)
MarketBeat's community ratings are surveys of what our community members think about Colony Capital and other stocks. Vote "Outperform" if you believe CLNY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLNY will underperform the S&P 500 over the long term. You may vote once every thirty days.
